Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra.

× No keyword cloud information.

8 in total

Review 1. [Cutaneous amyloidosis].

Authors: S Schreml; R-M Szeimies; M Landthaler; P Babilas
Journal: Hautarzt Date: 2011-01 Impact factor: 0.751

2. [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors: B Manger; M Gaubitz; H Michels
Journal: Z Rheumatol Date: 2009-11 Impact factor: 1.372

3. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.

Authors: Denis Gris; Zhengmao Ye; Heather A Iocca; Haitao Wen; Robin R Craven; Pavel Gris; Max Huang; Monika Schneider; Stephen D Miller; Jenny P-Y Ting
Journal: J Immunol Date: 2010-06-23 Impact factor: 5.422

4. Treatment of Inflammatory Diseases with IL-1 Blockade.

Authors: Charles A Dinarello
Journal: Curr Otorhinolaryngol Rep Date: 2018-03-07

5. Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS).

Authors: Ori Toker; Philip J Hashkes
Journal: Biologics Date: 2010-05-25

Review 6. Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors: Charles A Dinarello
Journal: Immunol Rev Date: 2018-01 Impact factor: 12.988

Review 7. NOD-like receptors and inflammation.

Authors: Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal: Arthritis Res Ther Date: 2008-11-25 Impact factor: 5.156

Review 8. Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors: Giulio Cavalli; Charles A Dinarello
Journal: Front Pharmacol Date: 2018-11-06 Impact factor: 5.810

8 in total